A detailed history of Quent Capital, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Quent Capital, LLC holds 1,882 shares of DXCM stock, worth $143,540. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,882
Previous 2,603 27.7%
Holding current value
$143,540
Previous $295,000 57.29%
% of portfolio
0.01%
Previous 0.03%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$64.0 - $116.06 $46,144 - $83,679
-721 Reduced 27.7%
1,882 $126,000
Q2 2024

Jul 08, 2024

BUY
$110.31 - $140.45 $2,757 - $3,511
25 Added 0.97%
2,603 $295,000
Q1 2024

May 02, 2024

BUY
$114.22 - $140.1 $3,769 - $4,623
33 Added 1.3%
2,578 $357,000
Q4 2023

Jun 14, 2024

BUY
$75.49 - $124.16 $20,004 - $32,902
265 Added 11.62%
2,545 $315,000
Q4 2023

Jan 19, 2024

BUY
$75.49 - $124.16 $20,004 - $32,902
265 Added 11.62%
2,545 $315,000
Q3 2023

Jun 14, 2024

SELL
$86.06 - $137.93 $86 - $137
-1 Reduced 0.04%
2,280 $212,000
Q3 2023

Oct 10, 2023

SELL
$86.06 - $137.93 $86 - $137
-1 Reduced 0.04%
2,280 $212,000
Q2 2023

Jun 14, 2024

SELL
$112.47 - $130.98 $2,249 - $2,619
-20 Reduced 0.87%
2,281 $293,000
Q2 2023

Jul 10, 2023

SELL
$112.47 - $130.98 $2,249 - $2,619
-20 Reduced 0.87%
2,281 $293,000
Q1 2023

Jun 14, 2024

SELL
$104.0 - $122.92 $28,808 - $34,048
-277 Reduced 10.74%
2,301 $267,000
Q1 2023

Apr 05, 2023

BUY
$104.0 - $122.92 $22,984 - $27,165
221 Added 10.63%
2,301 $267,000
Q4 2022

Jan 19, 2023

SELL
$84.98 - $122.67 $2,039 - $2,944
-24 Reduced 1.14%
2,080 $0
Q3 2022

Nov 10, 2022

BUY
$76.35 - $94.18 $4,581 - $5,650
60 Added 2.94%
2,104 $169,000
Q2 2022

Aug 08, 2022

BUY
$67.99 - $132.89 $104,704 - $204,650
1,540 Added 305.56%
2,044 $152,000
Q1 2022

May 12, 2022

BUY
$94.08 - $130.2 $10,913 - $15,103
116 Added 29.9%
504 $258,000
Q4 2021

Feb 28, 2022

BUY
$129.87 - $162.82 $50,389 - $63,174
388 New
388 $208,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Quent Capital, LLC Portfolio

Follow Quent Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quent Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quent Capital, LLC with notifications on news.